1
|
Woods LM, Rachet B, O'Connell DL, Lawrence G, Coleman MP. Are international differences in breast cancer survival between Australia and the UK present amongst both screen-detected women and non-screen-detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006. Int J Cancer 2016; 138:2404-14. [PMID: 26756306 PMCID: PMC4788140 DOI: 10.1002/ijc.29984] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Accepted: 11/30/2015] [Indexed: 11/30/2022]
Abstract
We examined survival in screened-detected and non-screen-detected women diagnosed in the West Midlands (UK) and New South Wales (Australia) in order to evaluate whether international differences in survival are related to early diagnosis, or to other factors relating to the healthcare women receive. Data for women aged 50 - 65 years who had been eligible for screening from 50 years were examined. Data for 5,628 women in West Midlands and 6,396 women in New South Wales were linked to screening service records (mean age at diagnosis 53.7 years). We estimated net survival and modelled the excess hazard ratio of breast cancer death by screening status. Survival was lower for women in the West Midlands than in New South Wales (5-year net survival 90.9% [95% CI 89.9%-91.7%] compared with 93.4% [95% CI 92.6%-94.1%], respectively). The difference was greater between the two populations of non-screen-detected women (4.9%) compared to between screen-detected women, (1.8% after adjustment for lead-time and over-diagnosis). The adjusted excess hazard ratio of breast cancer death for West Midlands compared with New South Wales was greater in the non-screen-detected group (EHR 2.00, 95% CI 1.70 - 2.31) but not significantly different to that for women whose cancer had been screen-detected (EHR 1.72, 95% CI 0.87 - 2.56). In this study more than one in three breast cancer deaths in the West Midlands would have been avoided if survival had been the same as in New South Wales. The possibility that women in the UK receive poorer treatment is an important potential explanation which should be examined with care.
Collapse
Affiliation(s)
- Laura M. Woods
- Cancer Research UK Cancer Survival GroupDepartment of Non‐Communicable Disease Epidemiology, London School of Hygiene and Tropical MedicineLondonWC1E 7HT
| | - Bernard Rachet
- Cancer Research UK Cancer Survival GroupDepartment of Non‐Communicable Disease Epidemiology, London School of Hygiene and Tropical MedicineLondonWC1E 7HT
| | | | - Gill Lawrence
- Breast Cancer Audit Consultant and Former DirectorWest Midlands Cancer Intelligence Unit, Public Health Building, University of BirminghamBirminghamB15 2TT
| | - Michel P. Coleman
- Cancer Research UK Cancer Survival GroupDepartment of Non‐Communicable Disease Epidemiology, London School of Hygiene and Tropical MedicineLondonWC1E 7HT
| |
Collapse
|
2
|
Woods LM, Rachet B, O'Connell D, Lawrence G, Coleman MP. Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006. Int J Cancer 2016; 138:2396-403. [PMID: 26756181 PMCID: PMC4833186 DOI: 10.1002/ijc.29983] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Revised: 11/04/2015] [Accepted: 11/25/2015] [Indexed: 12/05/2022]
Abstract
Women diagnosed with breast cancer in the UK display marked differences in survival between categories defined by socio-economic deprivation. Timeliness of diagnosis is one of the possible explanations for these patterns. Women whose cancer is screen-detected are more likely to be diagnosed at an earlier stage. We examined deprivation and screening-specific survival in order to evaluate the role of early diagnosis upon deprivation-specific survival differences in the West Midlands (UK) and New South Wales (Australia). We estimated net survival for women aged 50-65 years at diagnosis and whom had been continuously eligible for screening from the age of 50. Records for 5,628 women in West Midlands (98.5% of those eligible, mean age at diagnosis 53.7 years) and 6,396 women in New South Wales (99.9% of those eligible, mean age at diagnosis 53.8 years). In New South Wales, survival was similar amongst affluent and deprived women, regardless of whether their cancer was screen-detected or not. In the West Midlands, there were large and persistent differences in survival between affluent and deprived women. Deprivation differences were similar between the screen-detected and non-screen detected groups. These differences are unlikely to be solely explained by artefact, or by patient or tumour factors. Further investigations into the timeliness and appropriateness of the treatments received by women with breast cancer across the social spectrum in the UK are warranted.
Collapse
Affiliation(s)
- Laura M. Woods
- Cancer Research UK Cancer Survival Group, Non‐Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical MedicineKeppel StreetLondonUnited Kingdom
| | - Bernard Rachet
- Cancer Research UK Cancer Survival Group, Non‐Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical MedicineKeppel StreetLondonUnited Kingdom
| | - Dianne O'Connell
- Cancer Research Division, Cancer Council NSWKings CrossNew South WalesAustralia
| | - Gill Lawrence
- Breast Cancer Audit Consultant and Former Director, West Midlands Cancer Intelligence Unit, Public Health Building, University of BirminghamBirminghamEngland
| | - Michel P. Coleman
- Cancer Research UK Cancer Survival Group, Non‐Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical MedicineKeppel StreetLondonUnited Kingdom
| |
Collapse
|
3
|
Abstract
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high-quality data from an additional number of population-based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population-based cancer registries (2009-2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000-2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age-standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (-1.4% per year; P < .05) and females (-1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations.
Collapse
Affiliation(s)
- Wanqing Chen
- Deputy Director, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China
| | - Rongshou Zheng
- Associate Researcher, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China
| | - Peter D Baade
- Senior Research Fellow, Cancer Council Queensland, Brisbane, Queensland, Australia
| | - Siwei Zhang
- Associate Professor, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China
| | - Hongmei Zeng
- Associate Professor, National Office for Cancer Prevention and Control, National Cancer Center, Beijing, China
| | - Freddie Bray
- Head, Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
| | - Ahmedin Jemal
- Vice President, Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA
| | - Xue Qin Yu
- Research Fellow, Cancer Council New South Wales, Sydney, New South Wales, Australia
- Adjunct Lecturer, Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia
| | - Jie He
- Director, National Cancer Center, Beijing, China
| |
Collapse
|
4
|
Pascoe SW, Veitch C, Crossland LJ, Beilby JJ, Spigelman A, Stubbs J, Harris MF. Patients' experiences of referral for colorectal cancer. BMC FAMILY PRACTICE 2013; 14:124. [PMID: 23972115 PMCID: PMC3765755 DOI: 10.1186/1471-2296-14-124] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/18/2013] [Accepted: 08/20/2013] [Indexed: 11/30/2022]
Abstract
Background Outcomes for colorectal cancer patients vary significantly. Compared to other countries, Australia has a good record with patient outcomes, yet there is little information available on the referral pathway. This paper explores the views of Australian patients and their experiences of referral for colorectal cancer treatment following diagnosis; the aim was to improve our understanding of the referral pathway and guide the development of future interventions. Methods A purposive sampling strategy was used, recruiting 29 patients representing urban and rural areas from 3 Australian states who participated in 4 focus groups. Seven patients provided individual interviews to supplement the data. Recordings were transcribed verbatim, data was coded with NVivo software and analysed thematically before deductive analysis. Results Four aspects of the referral process were identified by patients, namely detection/diagnosis, referral for initial treatment/specialist care, the roles of the GP/specialist, and the patient’s perceived involvement in the process. The referral process was characterised by a lack of patient involvement, with few examples of shared decision-making and few examples of limited choice. However, patients did not always feel they had the knowledge to make informed decisions. Information exchange was highly valued by patients when it occurred, and it increased their satisfaction with the process. Other factors mediating care included the use of the public versus private health system, the quality of information exchange (GP to specialist and GP to patient), continuity of care between GP and specialist, and the extent of information provision when patients moved between specialist and GP care. Conclusions Patients described poor GP continuity, ad hoc organisational systems and limited information exchange, at both interpersonal and inter-organisational levels, all leading to sub-optimal care. Implementation of a system of information feedback to GPs and engagement with them might improve information exchange for patients, enabling them to be more involved in improved referral outcomes.
Collapse
Affiliation(s)
- Shane W Pascoe
- UNSW Research Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, UNSW, Sydney, Australia.
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Ito Y, Ioka A, Tsukuma H, Ajiki W, Sugimoto T, Rachet B, Coleman MP. Regional differences in population-based cancer survival between six prefectures in Japan: application of relative survival models with funnel plots. Cancer Sci 2009; 100:1306-11. [PMID: 19432897 PMCID: PMC11158017 DOI: 10.1111/j.1349-7006.2009.01170.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2009] [Revised: 03/03/2009] [Accepted: 03/15/2009] [Indexed: 11/28/2022] Open
Abstract
We used new methods to examine differences in population-based cancer survival between six prefectures in Japan, after adjustment for age and stage at diagnosis. We applied regression models for relative survival to data from population-based cancer registries covering each prefecture for patients diagnosed with stomach, lung, or breast cancer during 1993-1996. Funnel plots were used to display the excess hazard ratio (EHR) for each prefecture, defined as the excess hazard of death from each cancer within 5 years of diagnosis relative to the mean excess hazard (in excess of national background mortality by age and sex) in all six prefectures combined. The contribution of age and stage to the EHR in each prefecture was assessed from differences in deviance-based R(2) between the various models. No significant differences were seen between prefectures in 5-year survival from breast cancer. For cancers of the stomach and lung, EHR in Osaka prefecture were above the upper 95% control limits. For stomach cancer, the age- and stage-adjusted EHR in Osaka were 1.29 for men and 1.43 for women, compared with Fukui and Yamagata. Differences in the stage at diagnosis of stomach cancer appeared to explain most of this excess hazard (61.3% for men, 56.8% for women), whereas differences in age at diagnosis explained very little (0.8%, 1.3%). This approach offers the potential to quantify the impact of differences in stage at diagnosis on time trends and regional differences in cancer survival. It underlines the utility of population-based cancer registries for improving cancer control.
Collapse
Affiliation(s)
- Yuri Ito
- Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
| | | | | | | | | | | | | |
Collapse
|
6
|
Woods LM, Rachet B, O'Connell D, Lawrence G, Tracey E, Willmore A, Coleman MP. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data. Int J Cancer 2009; 124:2391-9. [PMID: 19180628 DOI: 10.1002/ijc.24233] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Survival from breast cancer in the UK is lower than in other countries in Western Europe, the USA and Australia. However, these international differences have not yet been examined in relation to tumor characteristics, treatment, screening history or other prognostic factors. We calculated relative survival by age, period of diagnosis, category of unemployment and extent of disease for women diagnosed with breast cancer during the period 1980-2002 in New South Wales (Australia) and West Midlands (England). National cancer registry data for each country for the period 1990-1994 were also examined. The excess hazard ratio was modeled as a function of prognostic covariables. Survival in Australia and New South Wales was higher than in England and West Midlands, respectively. In both regions, survival was lower for more deprived women and for the elderly. These differences were greater in West Midlands. Survival from localized and regional disease in New South Wales was higher than in West Midlands, but survival from metastatic disease was similar. Differences in breast cancer survival are unlikely to be entirely due to differences in data quality or to limitations of the analyses, although the measure of extent of disease used may not have been adequate to elucidate the effect of stage fully. One possible causal explanation is that the management of breast cancer differs between these regions. Further research should acquire better data on stage and investigate the effect of comorbidity and of patterns of care upon the difference in breast cancer survival between England and Australia.
Collapse
Affiliation(s)
- Laura M Woods
- Cancer Research UK Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom.
| | | | | | | | | | | | | |
Collapse
|
7
|
Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008; 19:1383-90. [PMID: 18704715 DOI: 10.1007/s10552-008-9210-1] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2008] [Accepted: 07/09/2008] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To assess the impact of socio-economic status (SES) on cancer survival in the state of New South Wales (NSW), Australia. METHODS Patients diagnosed with one of 13 major cancers during 1992-2000 in NSW were followed-up to the end of 2001. The effect of SES on survival was estimated for each individual cancer and all 13 cancers combined using multivariable modeling. The numbers of lives that could be extended if all people had the same level of excess risk of death due to cancer as patients in the highest SES areas were also estimated. RESULTS There were highly statistically significant variations in survival across SES groups for four cancers: stomach, liver, lung, and breast and all 13 cancers combined. Variation remained highly significant after adjusting for disease stage. Patients in lower SES areas had 10-20% higher excess risk than those in the highest SES areas. In total, there were 3,346 lives potentially extendable beyond 5 years; the highest number was for lung cancer (756). CONCLUSION The significantly worse survival in lower SES areas from cancers of the stomach, liver, lung, and breast may be due to poorer access to high-quality cancer care. Estimates of the number of lives potentially extendable by improving cancer survival in lower SES areas suggest that priority should be given to improving lung cancer care in lower SES areas in NSW, Australia.
Collapse
Affiliation(s)
- Xue Qin Yu
- Cancer Council, New South Wales, Sydney, Australia.
| | | | | | | |
Collapse
|
8
|
Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, e Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9:730-56. [PMID: 18639491 DOI: 10.1016/s1470-2045(08)70179-7] [Citation(s) in RCA: 816] [Impact Index Per Article: 51.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
9
|
Jiwa M, Gordon M, Arnet H, Ee H, Bulsara M, Colwell B. Referring patients to specialists: a structured vignette survey of Australian and British GPs. BMC FAMILY PRACTICE 2008; 9:2. [PMID: 18194578 PMCID: PMC2262087 DOI: 10.1186/1471-2296-9-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/21/2007] [Accepted: 01/15/2008] [Indexed: 11/16/2022]
Abstract
BACKGROUND In Australia and in the United Kingdom (UK) access to specialists is sanctioned by General Practitioners (GPs). It is important to understand how practitioners determine which patients warrant referral. METHODS A self-administered structured vignette postal survey of General Practitioners in Western Australia and the United Kingdom. Sixty-four vignettes describing patients with colorectal symptoms were constructed encompassing six clinical details. Nine vignettes, chosen at random, were presented to each individual. Respondents were asked if they would refer the patient to a specialist and how urgently. Logistic regression and parametric tests were used to analyse the data RESULTS We received 260 completed questionnaires. 58% of 'cancer vignettes' were selected for 'urgent' referral. 1632/2367 or 69% of all vignettes were selected for referral. After adjusting for clustering the model suggests that 38.4% of the variability is explained by all the clinical variables as well as the age and experience of the respondents. 1012 or 42.8 % of vignettes were referred 'urgently'. After adjusting for clustering the data suggests that 31.3 % of the variability is explained by the model. The age of the respondents, the location of the practice and all the clinical variables were significant in the decision to refer urgently. CONCLUSION GPs' referral decisions for patients with lower bowel symptoms are similar in the two countries. We question the wisdom of streaming referrals from primary care without a strong evidence base and an effective intervention for implementing guidelines. We conclude that implementation must take into account the profile of patients but also the characteristics of GPs and referral policies.
Collapse
Affiliation(s)
- Moyez Jiwa
- Western Australian Centre for Cancer and Palliative Care, Curtin University of Technology, Perth Western Australia, Australia
| | | | - Hayley Arnet
- Western Australian Centre for Cancer and Palliative Care, Curtin University of Technology, Perth Western Australia, Australia
| | - Hooi Ee
- Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
| | - Max Bulsara
- University of Western Australia, Perth, Western Australia, Australia
| | | |
Collapse
|
10
|
Brenner H, Hakulinen T. Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision. J Clin Epidemiol 2006; 59:570-5. [PMID: 16713519 DOI: 10.1016/j.jclinepi.2005.10.012] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2004] [Revised: 09/19/2005] [Accepted: 10/25/2005] [Indexed: 11/18/2022]
Abstract
BACKGROUND AND OBJECTIVE Period analysis provides more up-to-date estimates of cancer patient survival than traditional methods, but there is a trade-off between up-to-dateness and precision. Our objective was to compare the performance of period and complete analysis in terms of up-to-dateness and precision of survival estimates. STUDY DESIGN AND SETTING Five-year relative survival data actually observed for patients diagnosed with 1 of 20 common forms of cancer in Finland in 36 overlapping 5-year periods between 1958-1962 and 1993-1997 were compared with period estimates and various variants of complete estimates of 5-year relative survival potentially available during these periods. RESULTS At comparable levels of up-to-dateness, survival estimates from period analysis were more precise than survival estimates from complete analysis. At comparable levels of precision, period analysis provided more up-to-date survival estimates than did complete analysis. CONCLUSION These results further encourage more widespread use of period analysis as a standard tool for up-to-date monitoring of cancer patient survival by population-based cancer registries.
Collapse
Affiliation(s)
- Hermann Brenner
- Department of Epidemiology, German Center for Research on Aging, Bergheimer Strasse 20, D-69115 Heidelberg, Germany.
| | | |
Collapse
|